Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.4 Covid-19 impact analysis at global level
1.5 Data validation
1.6 Data sources
1.6.1 Secondary
1.6.1.1 Paid sources
1.6.1.2 Public sources
1.6.2 Primary
Chapter 2 Executive Summary
2.1 Organ transplant rejection medication industry 360º synopsis, 2018 – 2032 (USD Million)
2.1.1 Business trends
2.1.2 Region trends
2.1.3 Drug class trends
2.1.4 Transplant type trends
2.1.5 Distribution channel trends
Chapter 3 Organ Transplant Rejection Medication Market Insights
3.1 Industry landscape, 2018 – 2032 (USD Million)
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing organ transplant procedures due to chronic diseases
3.2.1.2 Technological advancements in organ transplantation and tissue engineering
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of organ transplantation procedures
3.2.2.2 Low availability of organs for transplantation
3.3 Growth potential analysis
3.3.1 By drug class
3.3.2 By transplant type
3.3.3 By distribution channel
3.4 COVID-19 impact analysis
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive positioning matrix, 2022
4.4 Strategic dashboard, 2022
Chapter 5 Organ Transplant Rejection Medication Market Estimates and Forecast, By Drug Class, 2018 - 2032 (USD Million)
5.1 Key trends, by drug class
5.2 Calcineurin inhibitors
5.3 Antibodies
5.4 Antiproliferative agents
5.5 mTOR inhibitor
5.6 Steroids
Chapter 6 Organ Transplant Rejection Medication Market Estimates and Forecast, By Transplant Type, 2018 - 2032 (USD Million)
6.1 Key trends, by transplant type
6.2 Kidney
6.3 Liver
6.4 Heart
6.5 Lung
6.6 Pancreas
6.7 Other transplant types
Chapter 7 Organ Transplant Rejection Medication Market Estimates and Forecast, By Distribution Channel, 2018 - 2032 (USD Million)
7.1 Key trends, by distribution channel
7.2 Hospital pharmacies
7.3 Retail pharmacies
7.4 Online pharmacies
Chapter 8 Organ Transplant Rejection Medication Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Switzerland
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 Astellas Pharma Inc.
9.2 Sanofi
9.3 Bristol-Myers Squibb Company
9.4 Novartis AG
9.5 F. Hoffmann-La Roche Ltd
9.6 Accord Healthcare Ltd
9.7 Viatris, Inc.
9.8 Dr. Reddy's Laboratories Ltd
9.9 Veloxis Pharmaceuticals A/S
9.10 GlaxoSmithKline plc
